United StatesCongress
hr 6625Bill

Equal Access to Therapeutics Act

To prohibit the Secretary of Health and Human Services from issuing guidance intended to restrict access to COVID-19 monoclonal antibody therapies and other treatments.

Introduced on February 7, 2022

House
Senate
President